OOIR: Observatory of International Research

Papers

(The TQCC of Annals of Internal Medicine is 6. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-05-01 to 2024-05-01.)

Article	Citations
The Incubation Period of Coronavirus Disease 2019 (COVID-19) From Publicly Reported Confirmed Cases: Estimation and Application	4308
Prevalence of Asymptomatic SARS-CoV-2 Infection	1888
Autopsy Findings and Venous Thromboembolism in Patients With COVID-19	1637
Variation in False-Negative Rate of Reverse Transcriptase Polymerase Chain Reaction–Based SARS-CoV-2 Tests by Time Since Exposure	1081
Attitudes Toward a Potential SARS-CoV-2 Vaccine	911
Psychological Impact of the COVID-19 Pandemic on Health Care Workers in Singapore	796
Racial and Ethnic Disparities in COVID-19–Related Infections, Hospitalizations, and Deaths	738
Pulmonary Arterial Thrombosis in COVID-19 With Fatal Outcome	574
Worldwide Effect of COVID-19 on Physical Activity: A Descriptive Study	566
Collision of the COVID-19 and Addiction Epidemics	525
Transmission of SARS-CoV-2: A Review of Viral, Host, and Environmental Factors	511
Diagnostic Testing for Severe Acute Respiratory Syndrome–Related Coronavirus 2	456
Epidemiology of and Risk Factors for Coronavirus Infection in Health Care Workers	437
Sixty-Day Outcomes Among Patients Hospitalized With COVID-19	434
Obesity and Mortality Among Patients Diagnosed With COVID-19: Results From an Integrated Health Care Organization	412
Awareness, Attitudes, and Actions Related to COVID-19 Among Adults With Chronic Conditions at the Onset of the U.S. Outbreak	400
COVID-19 and the Risk to Health Care Workers: A Case Report	400
The Proportion of SARS-CoV-2 Infections That Are Asymptomatic	395
Hydroxychloroquine in Nonhospitalized Adults With Early COVID-19	395
Systemic Lupus Erythematosus	340
Histopathologic Changes and SARS-CoV-2 Immunostaining in the Lung of a Patient With COVID-19	337
The Unrecognized Prevalence of Primary Aldosteronism	313
A War on Two Fronts: Cancer Care in the Time of COVID-19	291
Safety and Immunogenicity of a Third Dose of SARS-CoV-2 Vaccine in Solid Organ Transplant Recipients: A Case Series	277
Effectiveness of Adding a Mask Recommendation to Other Public Health Measures to Prevent SARS-CoV-2 Infection in Danish Mask Wearers	257

An Epidemic in the Midst of a Pandemic: Opioid Use Disorder and COVID-19	250
Incidence and Severity of COVID-19 in HIV-Positive Persons Receiving Antiretroviral Therapy	249
Effect of Immunosuppression on the Immunogenicity of mRNA Vaccines to SARS-CoV-2	247
Knowledge and Perceptions of COVID-19 Among the General Public in the United States and the United Kingdom: A Cross-sectional Online Survey	243
SARS-CoV-2 Isolation From Ocular Secretions of a Patient With COVID-19 in Italy With Prolonged Viral RNA Detection	236
Second International Guidelines for the Diagnosis and Management of Hereditary Hemorrhagic Telangiectasia	233
Autopsy Findings and Venous Thromboembolism in Patients With COVID-19	221
Probable Evidence of Fecal Aerosol Transmission of SARS-CoV-2 in a High-Rise Building	186
Depression	183
Locally Informed Simulation to Predict Hospital Capacity Needs During the COVID-19 Pandemic	183
Supporting Clinicians During the COVID-19 Pandemic	180
Comparative Effectiveness of Glucose-Lowering Drugs for Type 2 Diabetes	178
Reduced In-Person and Increased Telehealth Outpatient Visits During the COVID-19 Pandemic	170
This Time Must Be Different: Disparities During the COVID-19 Pandemic	170
SARS-CoV-2–Positive Sputum and Feces After Conversion of Pharyngeal Samples in Patients With COVID-19	169
When Epidemics Collide: Coronavirus Disease 2019 (COVID-19) and the Opioid Crisis	168
Chronic Obstructive Pulmonary Disease	166
Contact Settings and Risk for Transmission in 3410 Close Contacts of Patients With COVID-19 in Guangzhou, China	165
Body Mass Index and Risk for Intubation or Death in SARS-CoV-2 Infection	164
COVID-19: Peer Support and Crisis Communication Strategies to Promote Institutional Resilience	160
The Role of Medical Students During the COVID-19 Pandemic	160
COVID-19 Symptoms: Longitudinal Evolution and Persistence in Outpatient Settings	158
Development and Validation of a Modified Full Age Spectrum Creatinine-Based Equation to Estimate Glomerular Filtration Rate	157
The Sensitivity and Costs of Testing for SARS-CoV-2 Infection With Saliva Versus Nasopharyngeal Swabs	151
Use of Hydroxychloroquine and Chloroquine During the COVID-19 Pandemic: What Every Clinician Should Know	150
Patient Trajectories Among Persons Hospitalized for COVID-19	147
Loss of Smell and Taste in 2013 European Patients With Mild to Moderate COVID-19	146
A Rush to Judgment? Rapid Reporting and Dissemination of Results and Its Consequences Regarding the Use of Hydroxychloroquine for COVID-19	146
Conversion of Urine Protein–Creatinine Ratio or Urine Dipstick Protein to Urine Albumin–Creatinine Ratio for Use in Chronic Kidney Disease Screening and Prognosis	144
Hydroxychloroquine or Chloroquine for Treatment or Prophylaxis of COVID-19	141
Association Between Caseload Surge and COVID-19 Survival in 558 U.S. Hospitals, March to August 2020	133
Association Between ABO and Rh Blood Groups and SARS-CoV-2 Infection or Severe COVID-19 Illness	132
COVID-19 Mortality Risk in Down Syndrome: Results From a Cohort Study of 8 Million Adults	130
Ventilator Triage Policies During the COVID-19 Pandemic at U.S. Hospitals Associated With Members of the Association of Bioethics Program Directors	128
How Should U.S. Hospitals Prepare for Coronavirus Disease 2019 (COVID-19)?	126
Racial Disparities in COVID-19 Testing and Outcomes	123
Are Financial Payments From the Pharmaceutical Industry Associated With Physician Prescribing?	121
Cross-sectional Assessment of COVID-19 Vaccine Acceptance Among Health Care Workers in Los Angeles	119
Isradipine Versus Placebo in Early Parkinson Disease	117
Long-Term Rituximab Use to Maintain Remission of Antineutrophil Cytoplasmic Antibody–Associated Vasculitis	116
Comparison of Patients Infected With Delta Versus Omicron COVID-19 Variants Presenting to Paris Emergency Departments	115
Myasthenia Gravis Associated With SARS-CoV-2 Infection	114
Safety and Immunogenicity of Anti–SARS-CoV-2 Messenger RNA Vaccines in Recipients of Solid Organ Transplants	114
Detection of Monkeypox Virus in Anorectal Swabs From Asymptomatic Men Who Have Sex With Men in a Sexually Transmitted Infection Screening Program in Paris, France	112
Caution Warranted: Using the Institute for Health Metrics and Evaluation Model for Predicting the Course of the COVID-19 Pandemic	109
Diabetes Management in Chronic Kidney Disease: Synopsis of the 2020 KDIGO Clinical Practice Guideline	108
Sex and Gender Differences in Health: What the COVID-19 Pandemic Can Teach Us	105
Serodiagnostics for Severe Acute Respiratory Syndrome–Related Coronavirus 2	105
Masks for Prevention of Respiratory Virus Infections, Including SARS-CoV-2, in Health Care and Community Settings	105
Prevalence of Symptoms More Than Seven Months After Diagnosis of Symptomatic COVID-19 in an Outpatient Setting	104

Communication Skills in the Age of COVID-19	104
Spatial Inequities in COVID-19 Testing, Positivity, Confirmed Cases, and Mortality in 3 U.S. Cities	103
Delirium	103
A Health Opportunity Cost Threshold for Cost-Effectiveness Analysis in the United States	103
Intersecting U.S. Epidemics: COVID-19 and Lack of Health Insurance	101
Firearm Purchasing During the COVID-19 Pandemic: Results From the 2021 National Firearms Survey	101
A SARS-CoV-2 Cluster in an Acute Care Hospital	100
A Longitudinal Study of COVID-19 Sequelae and Immunity: Baseline Findings	100
Effectiveness of Surgical and Cotton Masks in Blocking SARS–CoV-2: A Controlled Comparison in 4 Patients	99
Risks and Impact of Angiotensin-Converting Enzyme Inhibitors or Angiotensin-Receptor Blockers on SARS-CoV-2 Infection in Adults	98
Sodium–Glucose Cotransporter-2 Inhibitors and the Risk for Diabetic Ketoacidosis	98
A Novel International Monkeypox Outbreak	98
Carditis After COVID-19 Vaccination With a Messenger RNA Vaccine and an Inactivated Virus Vaccine	97
SARS-CoV-2 Vaccine Effectiveness in a High-Risk National Population in a Real-World Setting	96
Risk for Serious Infection With Low-Dose Glucocorticoids in Patients With Rheumatoid Arthritis	96
Ventilation Techniques and Risk for Transmission of Coronavirus Disease, Including COVID-19	94
Racial and Ethnic Disparities in Excess Deaths During the COVID-19 Pandemic, March to December 2020	93
Antibody Response to a Fourth Messenger RNA COVID-19 Vaccine Dose in Kidney Transplant Recipients: A Case Series	92
Coronavirus Disease 2019 (COVID-19): Protecting Hospitals From the Invisible	92
QUADAS-C: A Tool for Assessing Risk of Bias in Comparative Diagnostic Accuracy Studies	91
Using Electronic Health Record Portals to Improve Patient Engagement: Research Priorities and Best Practices	90
The Contribution of the Age Distribution of Cases to COVID-19 Case Fatality Across Countries	88
Case Series of Thrombosis With Thrombocytopenia Syndrome After COVID-19 Vaccination—United States, December 2020 to August 2021	87
Characteristics, Outcomes, and Trends of Patients With COVID-19–Related Critical Illness at a Learning Health System in the United States	87
Insomnia	87
Historical Insights on Coronavirus Disease 2019 (COVID-19), the 1918 Influenza Pandemic, and Racial Disparities: Illuminating a Path Forward	87
The BNT162b2 (BioNTech/Pfizer) vaccine had 95% efficacy against COVID-19 ≥7 days after the 2nd dose	86
Effects of Interleukin-1β Inhibition on Incident Hip and Knee Replacement	86
Antibody Response After SARS-CoV-2 Infection and Implications for Immunity	85
Good Publication Practice (GPP) Guidelines for Company-Sponsored Biomedical Research: 2022 Update	85
Cardiac Endotheliitis and Multisystem Inflammatory Syndrome After COVID-19	85
Thrombosis With Thrombocytopenia After the Messenger RNA–1273 Vaccine	84
Estimation of Coronavirus Disease 2019 (COVID-19) Burden and Potential for International Dissemination of Infection From Iran	84
The Use of Rifaximin in the Prevention of Overt Hepatic Encephalopathy After Transjugular Intrahepatic Portosystemic Shunt	84
How to Safely Reopen Colleges and Universities During COVID-19: Experiences From Taiwan	83
Peripheral Neuropathy and All-Cause and Cardiovascular Mortality in U.S. Adults	82
Testing for Primary Aldosteronism and Mineralocorticoid Receptor Antagonist Use Among U.S. Veterans	81
Acute Cardiovascular Events Associated With Influenza in Hospitalized Adults	81
Evaluation of the Effects of Remdesivir and Hydroxychloroquine on Viral Clearance in COVID-19	80
Clinical Endpoints for Evaluating Efficacy in COVID-19 Vaccine Trials	79
Nirmatrelvir Plus Ritonavir for Early COVID-19 in a Large U.S. Health System	78
Surviving COVID-19 After Hospital Discharge: Symptom, Functional, and Adverse Outcomes of Home Health Recipients	75
Association Between Oral Corticosteroid Bursts and Severe Adverse Events	75
Pulmonary Hypertension	73
Insights From Rapid Deployment of a “Virtual Hospital” as Standard Care During the COVID-19 Pandemic	72
Is Comprehensive Geriatric Assessment Admission Avoidance Hospital at Home an Alternative to Hospital Admission for Older Persons?	70
Quantification of Occupational and Community Risk Factors for SARS-CoV-2 Seropositivity Among Health Care Workers in a Large U.S. Health Care System	69
Every Body Counts: Measuring Mortality From the COVID-19 Pandemic	69
Preterm Birth and Stillbirth During the COVID-19 Pandemic in Sweden: A Nationwide Cohort Study	69
Thrombosis, Bleeding, and the Observational Effect of Early Therapeutic Anticoagulation on Survival in Critically Ill Patients With COVID-19	69
Weight and Metabolic Changes After Switching From Tenofovir Disoproxil Fumarate to Tenofovir Alafenamide in People Living With HIV	69
The Impact of the COVID-19 Pandemic and Associated Control Measures on the Mental Health of the General Population	68
Thromboembolic Findings in COVID-19 Autopsies: Pulmonary Thrombosis or Embolism?	67
Long-Term Colorectal Cancer Incidence and Mortality After a Single Negative Screening Colonoscopy	67
The COVID-NMA Project: Building an Evidence Ecosystem for the COVID-19 Pandemic	67
Effectiveness of Belimumab After Rituximab in Systemic Lupus Erythematosus	66
Comparison of Knowledge and Information-Seeking Behavior After General COVID-19 Public Health Messages and Messages Tailored for Black and Latinx Communities	66
Obesity and COVID-19 in New York City: A Retrospective Cohort Study	66
Major Update: Remdesivir for Adults With COVID-19	66
Worsening Spread of Candida auris in the United States, 2019 to 2021	65
Long-Term Risk for Major Bleeding During Extended Oral Anticoagulant Therapy for First Unprovoked Venous Thromboembolism	65
Retail Alcohol and Tobacco Sales During COVID-19	64
Reporting and Implementing Interventions Involving Machine Learning and Artificial Intelligence	64
Delayed Denosumab Injections and Fracture Risk Among Patients With Osteoporosis	64
Deep Learning Using Chest Radiographs to Identify High-Risk Smokers for Lung Cancer Screening Computed Tomography: Development and Validation of a Prediction Model	63
Rifabutin-Based Triple Therapy (RHB-105) for Helicobacter pylori Eradication	63
Regulatory T Cells for Treating Patients With COVID-19 and Acute Respiratory Distress Syndrome: Two Case Reports	62
Cloth Masks May Prevent Transmission of COVID-19: An Evidence-Based, Risk-Based Approach	62
Postdiagnosis Smoking Cessation and Reduced Risk for Lung Cancer Progression and Mortality	62
Hydroxychloroquine as Postexposure Prophylaxis to Prevent Severe Acute Respiratory Syndrome Coronavirus 2 Infection	62
Qualitative Assessment of Rapid System Transformation to Primary Care Video Visits at an Academic Medical Center	61
Linked Color Imaging Focused on Neoplasm Detection in the Upper Gastrointestinal Tract	61
Alternative Dose Allocation Strategies to Increase Benefits From Constrained COVID-19 Vaccine Supply	61
Vitamin D Deficiency Increases Mortality Risk in the UK Biobank	60
College Campuses and COVID-19 Mitigation: Clinical and Economic Value	60
Effectiveness of Curcuma longa Extract for the Treatment of Symptoms and Effusion–Synovitis of Knee Osteoarthritis	60
Pharmacokinetics of Lopinavir and Ritonavir in Patients Hospitalized With Coronavirus Disease 2019 (COVID-19)	60
Type 1 Diabetes Mellitus	59
Treatment of Community-Acquired Pneumonia During the Coronavirus Disease 2019 (COVID-19) Pandemic	59
Pharmacologic Approaches to Glycemic Treatment of Type 2 Diabetes: Synopsis of the 2020 American Diabetes Association's Standards of Medical Care in Diabetes Clinical Guideline	59

Efficacy and Safety of Dapagliflozin According to Frailty in Heart Failure With Reduced Ejection Fraction	58
Effect of Acupuncture for Postprandial Distress Syndrome	58
Antibody Responses After SARS-CoV-2 mRNA Vaccination in Adults With Inflammatory Bowel Disease	57
Antinucleocapsid Antibodies After SARS-CoV-2 Infection in the Blinded Phase of the Randomized, Placebo-Controlled mRNA-1273 COVID-19 Vaccine Efficacy Clinical Trial	57
Cardiometabolic Disease Burden and Steroid Excretion in Benign Adrenal Tumors	57
SARS-CoV-2 Vaccines: Much Accomplished, Much to Learn	57
Masks and Face Coverings for the Lay Public	57
Remdesivir for Adults With COVID-19	56
Three-Year Outcomes of Bariatric Surgery in Patients With Obesity and Hypertension	56
Appropriate Use of Point-of-Care Ultrasonography in Patients With Acute Dyspnea in Emergency Department or Inpatient Settings: A Clinical Guideline From the American College of Physicians	56
Performance Evaluation of Serial SARS-CoV-2 Rapid Antigen Testing During a Nursing Home Outbreak	56
Toward Understanding COVID-19 Recovery: National Institutes of Health Workshop on Postacute COVID-19	56
Acute Pancreatitis	55
Long-Term Oncologic Outcomes After Laparoscopic Versus Open Resection for Colorectal Liver Metastases	55
Association Between Treatment With Apixaban, Dabigatran, Rivaroxaban, or Warfarin and Risk for Osteoporotic Fractures Among Patients With Atrial Fibrillation	55
Preventing Hospital Readmission for Patients With Comorbid Substance Use Disorder	54
Sodium–Glucose Cotransporter-2 Inhibitors Versus Glucagon-like Peptide-1 Receptor Agonists and the Risk for Cardiovascular Outcomes in Routine Care Patients With Diabetes Across Categories of Cardiova	54
Management of Acute Pain From Non–Low Back, Musculoskeletal Injuries	54
COVID-19 Vaccine: Promoting Vaccine Acceptance	53
Appropriate Use of Short-Course Antibiotics in Common Infections: Best Practice Advice From the American College of Physicians	53
Addressing Postpandemic Clinician Mental Health	53
Contributions of Adenocarcinoma and Carcinoid Tumors to Early-Onset Colorectal Cancer Incidence Rates in the United States	53
Environment and Personal Protective Equipment Tests for SARS-CoV-2 in the Isolation Room of an Infant With Infection	53
Estimation of Breast Cancer Overdiagnosis in a U.S. Breast Screening Cohort	52
Salivary Detection of COVID-19	52
Speed Versus Efficacy: Quantifying Potential Tradeoffs in COVID-19 Vaccine Deployment	52
Clinical Practice Guidelines From the Association for the Advancement of Blood and Biotherapies (AABB): COVID-19 Convalescent Plasma	52
Characteristics of COVID-19 in Homeless Shelters	51
Vitamin D and Risk for Type 2 Diabetes in People With Prediabetes	51
Effect of Molnupiravir on Biomarkers, Respiratory Interventions, and Medical Services in COVID-19	50
Risk Compensation and COVID-19 Vaccines	50
Nonpharmacologic and Pharmacologic Management of Acute Pain From Non–Low Back, Musculoskeletal Injuries in Adults: A Clinical Guideline From the American College of Physicians and American Academy of	49
Frailty and Clinical Outcomes of Direct Oral Anticoagulants Versus Warfarin in Older Adults With Atrial Fibrillation	49
Effect of Timing of and Adherence to Social Distancing Measures on COVID-19 Burden in the United States	49
Efficacy of Acupuncture for Chronic Prostatitis/Chronic Pelvic Pain Syndrome	49
Patient Characteristics and Costs Associated With COVID-19–Related Medical Care Among Medicare Fee-for-Service Beneficiaries	48
Coronavirus Disease 2019 (COVID-19) and Firearms in the United States: Will an Epidemic of Suicide Follow?	48
Effectiveness of Inactivated COVID-19 Vaccines Against Illness Caused by the B.1.617.2 (Delta) Variant During an Outbreak in Guangdong, China	48
Multiple Sclerosis	48
Responses to a Neutralizing Monoclonal Antibody for Hospitalized Patients With COVID-19 According to Baseline Antibody and Antigen Levels	48
Comparing Video-Based, Telehealth-Delivered Exercise and Weight Loss Programs With Online Education on Outcomes of Knee Osteoarthritis	47
Association Between Bariatric Surgery and All-Cause Mortality: A Population-Based Matched Cohort Study in a Universal Health Care System	47
Racism and Health in the United States: A Policy Statement From the American College of Physicians	47
Safety and Efficacy of Checkpoint Inhibition in Patients With Melanoma and Preexisting Autoimmune Disease	47
The Effects of Four Doses of Vitamin D Supplements on Falls in Older Adults	46
Effects of Intensive Blood Pressure Treatment on Orthostatic Hypotension	46
Rivaroxaban Is Associated With Higher Rates of Gastrointestinal Bleeding Than Other Direct Oral Anticoagulants	46
Clinical Validity of Serum Antibodies to SARS-CoV-2	46
Sexual Health in the SARS-CoV-2 Era	46
Neutralization of SARS-CoV-2 Variants in Transplant Recipients After Two and Three Doses of mRNA-1273 Vaccine	46
Prevalence of Asymptomatic SARS-CoV-2 Infection	45
Age- and Weight-Adapted Dose of Prasugrel Versus Standard Dose of Ticagrelor in Patients With Acute Coronary Syndromes	45
Research and Reporting Considerations for Observational Studies Using Electronic Health Record Data	45
Monkeypox: Avoiding the Mistakes of Past Infectious Disease Epidemics	45
Diabetes Management in Chronic Kidney Disease: Synopsis of the KDIGO 2022 Clinical Practice Guideline Update	44
Medication for Opioid Use Disorder: A National Survey of Primary Care Physicians	44
Current Insights Into Respiratory Virus Transmission and Potential Implications for Infection Control Programs	44
Absence of Humoral Response After Two-Dose SARS-CoV-2 Messenger RNA Vaccination in Patients With Rheumatic and Musculoskeletal Diseases: A Case Series	44
Benefits and Harms of Prescription Drugs and Supplements for Treatment of Clinical Alzheimer-Type Dementia	43
A Double-Blind, Randomized, Placebo-Controlled Phase 1 Study of Ad26.ZIKV.001, an Ad26-Vectored Anti–Zika Virus Vaccine	43
The Incidence of SARS-CoV-2 Reinfection in Persons With Naturally Acquired Immunity With and Without Subsequent Receipt of a Single Dose of BNT162b2 Vaccine	43
Association of Sugar-Sweetened, Artificially Sweetened, and Unsweetened Coffee Consumption With All-Cause and Cause-Specific Mortality	43
Chest Computed Tomography for Detection of Coronavirus Disease 2019 (COVID-19): Don't Rush the Science	43
Association Between Mortality and Levels of Autonomous Cortisol Secretion by Adrenal Incidentalomas	42
Characteristics and Mortality of Hospitalized Patients With COVID-19 in Iran: A National Retrospective Cohort Study	42
Where Is the ID in COVID-19?	42
Lipodystrophic Nonalcoholic Fatty Liver Disease Induced by Immune Checkpoint Blockade	42
Designing, Conducting, and Reporting Clinical Decision Support Studies: Recommendations and Call to Action	42
Inflammatory Response Cells During Acute Respiratory Distress Syndrome in Patients With Coronavirus Disease 2019 (COVID-19)	42
Knowledge Gaps, Challenges, and Opportunities in Health and Prevention Research for Asian Americans, Native Hawaiians, and Pacific Islanders: A Report From the 2021 National Institutes of Health Works	42
Medical Schools as Racialized Organizations: A Primer	42
Symptoms After COVID-19 Vaccination in Patients With Persistent Symptoms After Acute Infection: A Case Series	42
Clinical Trends Among U.S. Adults Hospitalized With COVID-19, March to December 2020	41
SARS-CoV-2 Vaccine Antibody Response and Breakthrough Infection in Patients Receiving Dialysis	41
Effects of Tai Chi or Conventional Exercise on Central Obesity in Middle-Aged and Older Adults	41
Stepped Exercise Program for Patients With Knee Osteoarthritis	41
Development of Severe COVID-19 Adaptive Risk Predictor (SCARP), a Calculator to Predict Severe Disease or Death in Hospitalized Patients With COVID-19	41
Clinical and Economic Effects of Widespread Rapid Testing to Decrease SARS-CoV-2 Transmission	41
Histopathologic Changes and SARS-CoV-2 Immunostaining in the Lung of a Patient With COVID-19	41
Identifying Equitable Screening Mammography Strategies for Black Women in the United States Using Simulation Modeling	41
Midodrine for the Prevention of Vasovagal Syncope	40
Clinician Perspectives on Caring for Dying Patients During the Pandemic	40
Comparison of SARS-CoV-2 Reverse Transcriptase Polymerase Chain Reaction and BinaxNOW Rapid Antigen Tests at a Community Site During an Omicron Surge	40
Locally Informed Simulation to Predict Hospital Capacity Needs During the COVID-19 Pandemic	39
Risk for Reinfection After SARS-CoV-2: A Living, Rapid Review for American College of Physicians Practice Points on the Role of the Antibody Response in Conferring Immunity Following SARS-CoV-2 Infect	39
Dynamics and Correlation Among Viral Positivity, Seroconversion, and Disease Severity in COVID-19	39
Management of Blood Pressure in Patients With Chronic Kidney Disease Not Receiving Dialysis: Synopsis of the 2021 KDIGO Clinical Practice Guideline	39
Performance of the European Society of Cardiology 0/1-Hour, 0/2-Hour, and 0/3-Hour Algorithms for Rapid Triage of Acute Myocardial Infarction	39
Transparent Reporting of Multivariable Prediction Models in Journal and Conference Abstracts: TRIPOD for Abstracts	39
Medical Masks Versus N95 Respirators for Preventing COVID-19 Among Health Care Workers	39
Cost-Effectiveness of Long-Acting Injectable HIV Preexposure Prophylaxis in the United States	38
A Framework for the Development of Living Practice Guidelines in Health Care	38
Hearing Loss	38
Managing COVID-19 in a Novel, Rapidly Deployable Community Isolation Quarantine Facility	38
Sickle Cell Disease	38